In conclusion, our study demonstrates that ACE2 overexpression decreases the mortality of rats with doxorubicin-induced cardiomyopathy by decreasing apoptosis, inflammatory response, oxidative stress, myocardial fibrosis and improving left ventricular remodeling and cardiac function. Here, ACE2 is linked to Myocardial fibrosis.